MedTrace Logo

Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study

NCT01352819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2022-11-09

No results posted yet for this study

Summary

The objective of this study is to evaluate the effectiveness of Deep Brain Stimulation as an adjunctive treatment for reducing some of the symptoms of advanced, levodopa-responsive Parkinson's disease that are not adequately controlled with medication.

It is the first study in Parkinson patients outside the US with a Deep Brain Stimulation system using constant current instead of constant voltage and using a lead with an active electrode tip.

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Jan Vesper, Prof · Universitätsklinukum Dusseldorf

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-03-31
Completion
2013-12-31

Countries

  • France
  • Germany
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01352819 on ClinicalTrials.gov